A Web-based Bystander Education Program (RealConsent)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01903876 |
|
Recruitment Status :
Completed
First Posted : July 19, 2013
Results First Posted : July 23, 2014
Last Update Posted : July 23, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Sexual Violence | Behavioral: Bystander & Sexual Violence Prevention Behavioral: General Health Promotion | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 743 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | Preventing Violence Against Women: A Web-based Approach |
| Study Start Date : | February 2010 |
| Actual Primary Completion Date : | May 2011 |
| Actual Study Completion Date : | May 2011 |
| Arm | Intervention/treatment |
|---|---|
|
Placebo Comparator: General Health promotion
A 3-hour general mental health web-based program.
|
Behavioral: General Health Promotion
This general health promotion web-based program is 3-hours and provides a range of activities related to reducing day-to day stress and alleviating anxiety through meditation and exercise.
Other Name: Stress & Mood Management |
|
Experimental: Bystander & Sexual Violence Prevention
A 3-hour web-based program designed to teach male college student bystanders to intervene.
|
Behavioral: Bystander & Sexual Violence Prevention
This 3-hour web-based program consists of six 30-minute modules that are interactive and range in number of segments (1-14) and types of activities. Each of the modules involves interactivity, didactic activities and two episodes of a serial drama, which allows for the modeling of positive behaviors and illustrate both positive and negative outcome expectations for intervening and for perpetrating abuse against women. Behaviors modeled include communicating with female sex partners, obtaining informed consent to have sex, and intervening to prevent abuse from taking place.
Other Name: RealConsent |
- Prosocial Intervening Behavior [ Time Frame: 6 months ]This scale is the Reactions to Offensive Language and Behavior (ROLB) index that measures whether or not men confronted inappropriate behaviors of other men. We used the 7-item self-behavior subscale plus an additional 8 items, which directly reflected the content of RealConsent. A series of 15 potential intervening situations were presented and participants were asked to indicate whether they had experienced this situation in past 6 months (yes/no), and whether they had intervened (yes/no). The scale ranged from 0% (did not intervene anytime) to 100% (intervened every time).
- Sexual Violence Perpetration [ Time Frame: 6 months ]This scale is the Conflict Tactics Scale revised, Sexual Coercion Subscale and assessed the number of sexually coercive/violent behaviors engaged in during the past 6 months. The index ranges from 0 (no engagement in any sexual violence) to 7 (engaged in all 7 sexually violent behaviors).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 24 Years (Adult) |
| Sexes Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Student matriculated at Georgia State University
- Male
- 18 to 24
- Undergraduate
- Self-identify as heterosexual or bisexual
Exclusion Criteria:
- Graduate student
- Self-identify as homosexual
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01903876
| United States, Georgia | |
| Georgia State University | |
| Atlanta, Georgia, United States, 30303 | |
| Principal Investigator: | Laura F Salazar, PhD | Emory University |
| Responsible Party: | Laura F Salazar, Assistant Professor, Emory University |
| ClinicalTrials.gov Identifier: | NCT01903876 |
| Other Study ID Numbers: |
IRB00000472 R49CE000892 ( U.S. NIH Grant/Contract ) EmoryVAW ( Other Identifier: Other ) |
| First Posted: | July 19, 2013 Key Record Dates |
| Results First Posted: | July 23, 2014 |
| Last Update Posted: | July 23, 2014 |
| Last Verified: | July 2014 |

